Application 215975
- Type
- ANDA
- Sponsor
- MSN LABS PVT LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LETROZOLE;VRIBOCICLIB SUCCINATE | LETROZOLE;RIBOCICLIB SUCCINATE | TABLET;ORAL | 200MG;2.5MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.